Skip to main content
Fig. 5 | BMC Nephrology

Fig. 5

From: Construction and validation of a prediction model for the risk of citrate accumulation in patients with hepatic insufficiency receiving continuous renal replacement therapy with citrate anticoagulation

Fig. 5

DCA of the nomogram. a DCA in the training group. b DCA in the validation group. Red-solid line: The patient does not apply the nomogram and the net benefit is zero; Grey-solid line: All patients are treated by the nomogram. The area enclosed by the three lines presents the clinical utility of the nomogram. DCA: decision curve analysis

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us